Finance

Lists
300482:SHE
Guangzhou Wondfo Biotech Co Ltd
CNÂ¥16.35
+1.49%
(+0.24) 1D
Nov 4, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300482...
Open
CNÂ¥16.10
High
CNÂ¥16.45
Low
CNÂ¥16.08
Mkt. cap
7.54B
Avg. vol.
4.87M
Volume
6.20M
Dividend
1.35%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 2, 2026
52-wk high
CNÂ¥26.29
52-wk low
CNÂ¥15.05
EPS
-CNÂ¥0.10
Shares outstanding
468.15M
No. of employees
2K
Open
CNÂ¥16.10
High
CNÂ¥16.45
Low
CNÂ¥16.08
Mkt. cap
7.54B
Avg. vol.
4.87M
Volume
6.20M
Dividend
1.35%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 2, 2026
52-wk high
CNÂ¥26.29
52-wk low
CNÂ¥15.05
EPS
-CNÂ¥0.10
Shares outstanding
468.15M
No. of employees
2K
News stories
From web sources and news partners
About Guangzhou Wondfo Biotech Co Ltd
CEO-
Employees2.44K
FoundedNov 13, 1992
Headquarters-
SectorMedical device
Industry-
Websitewondfo.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
396.65M
581.74M
456.76M
530.39M
Cost of goods sold
238.24M
213.83M
164.92M
211.64M
Cost of revenue
238.24M
213.83M
164.92M
211.64M
Research and development expenses
71.60M
73.65M
64.20M
67.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
327.80M
177.81M
179.63M
183.51M
Operating expense
396.37M
267.63M
247.66M
234.62M
Total operating expenses
634.61M
481.47M
412.58M
446.25M
Operating income
-237.96M
100.28M
44.18M
84.13M
Other non operating income
7.75M
-13.32M
11.58M
-39.96M
EBT including unusual items
-241.31M
97.18M
43.38M
9.88M
EBT excluding unusual items
-224.63M
84.28M
32.84M
27.76M
Income tax expense
-45.22M
11.06M
4.34M
-3.14M
Effective tax rate
18.74%
11.38%
10.01%
-31.75%
Other operating expenses
3.96M
8.28M
7.46M
-16.32M
Net income
-196.76M
84.40M
38.12M
11.36M
Net profit margin
-49.61%
14.51%
8.35%
2.14%
Earnings per share
-
-
-
-
Interest and investment income
28.80M
4.76M
6.83M
13.71M
Interest expense
-7.00M
-7.45M
-7.23M
-52.64M
Net interest expenses
21.80M
-2.68M
-402.25K
-38.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
-181.85M
156.39M
98.84M
140.25M
Gain or loss from assets sale
-318.79K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps